Deccan Healthcare, an Indian developer of nutraceutical products which boost immunity and address chronic ailments, has received a Rs15crore (approximately $3.2m) equity financing from India’s Venture Capital firm Nexus Venture Partners.
Commenting on the deal, Mr Minto Gupta, Founder & CEO of Deccan Healthcare, said: “The funding will help us enhance our R&D efforts and our expansion plans. Deccan is launching a variety of nutraceuticals addressing specific life-style problems and will also explore export opportunities”.
Company’s key products include a flaxseed-based vegetarian Omega-3 which they sell under the OxyFlax and Nulife-ISB brand. It isanti-carcinogenic and anti-inflammatory and useful for cardiac care, bone health, diabetes prevention.
Sandeep Singhal of Nexus Venture Partners will join the Deccan Healthcare board.
The company is based out of Hyderabad, India.